AI assistant
Sending…
Teva Pharmaceutical Industries Ltd. — Board/Management Information 2012
May 8, 2012
7082_rns_2012-05-08_75db1c9c-9b15-4a2f-baa6-71254bbc231b.htm
Board/Management Information
Open in viewerOpens in your device viewer
_________ false
C002��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD.7217Corporation no: 520013954Stock Exchange/Market: ���310380P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267267 , 03-9267652 Fax: 03-9267519E.mail address: [email protected] of transmission: 08/05/2012 Time of broadcast: 23:37 23:36:06
Reference: 2012-02-121071
| Israel Securities Authority | Tel Aviv Stock Exchange | |||||
| www.isa.gov.il | www.tase.co.il |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
| Attached hereto is a report on Departure of J. Kevin Buchi and Lesley Russell Copper |
| KevinBnoticeFinal_isa.pdf |
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): |
| Previous names of reporting entity: |
| Date of revision of form structure: 14/03/2012 |
| - - - |
| Name of the Signatory: : Desheh Eyal , Position of Signatory in the reporting corporation: Chief Financial Officer , Name of Employer Company: . |
| Basel Telephone: 03-9267656 , Facsimile: 03-9148678 , E-mail: [email protected] 2 |
More from Teva Pharmaceutical Industries Ltd.
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Regulatory Filings
2026
May 28
Director's Dealing
2026
May 18
Director's Dealing
2026
May 18
Director's Dealing
2026
May 18
Director's Dealing
2026
May 18
Director's Dealing
2026
May 7
Director's Dealing
2026
May 7
Director's Dealing
2026
May 7